Cabazitaxel mushonga unoshandiswa kurapa gomarara, uri weboka remishonga inonzi “paclitaxel analogues”. Mishonga iyi inogona kutadzisa kukura uye kupatsanuka kwemabundu masero, nokudaro ichideredza kana kudzivirira kukura kwegomarara.
Cabazitaxel yakatanga kuwanikwa nevasayendisiti veNational Cancer Institute muUnited States.Mushure memakore etsvakurudzo nebudiriro, cabazitaxel yave mushonga unoshandiswa nevakawanda unorwisa gomarara mumakiriniki.Unogona kushandiswa kurapa marudzi mazhinji egomarara,kusanganisira gomarara rezamu. kenza yeovarian, isiri-diki cell cancer yemapapu, kenza yeprostate, kenza yemudumbu, colon cancer, zvichingodaro.
Therapeutic musimboti wecabazitaxelndiko kutadzisa kukura uye kuwanda kwebundu masero kuburikidza nekukanganisa maitiro avo eMitosis.Kunyanya, cabazitaxel inogona kusanganiswa neTubulin kudzivirira polymerization uye depolymerization yeTubulin, nokudaro kukanganisa Mitosis maitiro emasero emarara, zvichiita kuti masero asakwanise kupatsanura. uye kuwanda zvakajairika, uye pakupedzisira zvichizotungamira kune bundu cell kufa.
Cabazitaxelmushonga unokosha unopesana nekenza unopa tariro nemikana yevarwere vakawanda kurapa kenza.Nekuenderera mberi kwesayenzi uye teknolojia, zvinotendwa kuti kushanda uye kuchengeteka kwe cabazitaxel kuchawedzera kuvandudzwa.
Kuwedzerwa kuverenga:Hande Biotech yanga yakatarisana nekugadzirwa kwepaclitaxel kwemakore mazhinji, uye ibhizimusi rekugadzira rakazvimiririra repaclitaxel raw materials yemiti inobvisa anticancer mishonga inotenderwa nemasangano anodzora enyika akadai seUS FDA,European EDQM,Australia TGA,China. CFDA,India,Japan,etc.Yunnan Hande inopa zvemhando yepamusoroCabazitaxelraw materials, inowanikwa mustock.Kana uchizvida, ndapota inzwa wakasununguka kutibata chero nguva.
Nguva yekutumira: Jun-08-2023